AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules (Q38836223)
Jump to navigation
Jump to search
scientific article published on 10 September 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules |
scientific article published on 10 September 2015 |
Statements
1 reference
AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules (English)
1 reference
Sylvie M Guichard
1 reference
Jon Curwen
1 reference
Teeru Bihani
1 reference
Celina M D'Cruz
1 reference
James W T Yates
1 reference
Michael Grondine
1 reference
Zoe Howard
1 reference
Barry R Davies
1 reference
Graham Bigley
1 reference
Teresa Klinowska
1 reference
Kurt G Pike
1 reference
Martin Pass
1 reference
Christine M Chresta
1 reference
Urszula M Polanska
1 reference
Robert McEwen
1 reference
Oona Delpuech
1 reference
Stephen Green
1 reference
Sabina C Cosulich
1 reference
10 September 2015
1 reference
1 reference
Identifiers
1 reference